A Neurologist's Guide to Acute Migraine Therapy in the Emergency Room

Overview

Journal Neurohospitalist

Publisher Sage Publications

Date 2013 Aug 13

PMID 23936605

Citations 20

Authors

Amy A Gelfand

Peter J Goadsby

Affiliations

Soon will be listed here.

Abstract

Migraine is a common reason for visits to the emergency room. Attacks that lead patients to come to the emergency room are often more severe, refractory to home rescue medication, and have been going on for longer. All of these features make these attacks more challenging to treat. The purpose of this article is to review available evidence pertinent to the treatment of acute migraine in adults in the emergency department setting in order to provide neurologists with a rational approach to management. Drug classes and agents reviewed include opioids, dopamine receptor antagonists, triptans, nonsteroidal anti-inflammatory drugs, corticosteroids, and sodium valproate.

Citing Articles

Episodic Migraine in the Pediatric Population: Behavioral Therapies and other Non-Pharmacological Treatment Options.

Gazerani P Curr Pain Headache Rep. 2025; 29(1):57.

PMID: 40029442 PMC: 11876209. DOI: 10.1007/s11916-025-01366-3.

A Retrospective Analysis of Disease Epidemiology, Comorbidity Burden, Treatment Patterns, and Healthcare Resource Utilization of Migraine in the United Arab Emirates.

Terruzzi A, AlMadani A, Al-Rukn S, Farghaly M, Dallal S, Zayed M Pain Ther. 2024; 13(5):1235-1255.

PMID: 39030417 PMC: 11393247. DOI: 10.1007/s40122-024-00634-1.

Identifying therapeutic target genes for migraine by systematic druggable genome-wide Mendelian randomization.

Zhang C, He Y, Liu L J Headache Pain. 2024; 25(1):100.

PMID: 38867170 PMC: 11167905. DOI: 10.1186/s10194-024-01805-3.

The efficacy and safety of metoclopramide in relieving acute migraine attacks compared with other anti-migraine drugs: a systematic review and network meta-analysis of randomized controlled trials.

Abdelmonem H, Abdelhay H, Abdelwadoud G, Alhosini A, Ahmed A, Mohamed S BMC Neurol. 2023; 23(1):221.

PMID: 37291500 PMC: 10249175. DOI: 10.1186/s12883-023-03259-7.

Treating Vestibular Migraine When Pregnant and Postpartum: Progress, Challenges and Innovations.

Teelucksingh S, Murali Govind R, Dobson R, Nelson-Piercy C, Ovadia C Int J Womens Health. 2023; 15:321-338.

PMID: 36814528 PMC: 9940493. DOI: 10.2147/IJWH.S371491.

References

Goadsby P, Zanchin G, Geraud G, De Klippel N, Diaz-Insa S, Gobel H . Early vs. non-early intervention in acute migraine-'Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan. Cephalalgia. 2008; 28(4):383-91. DOI: 10.1111/j.1468-2982.2008.01546.x. View

Winner P, DAlessio D, Mathew N, Sadowsky C, Turkewitz L, Sheftell F . Office-based treatment of acute migraine with dihydroergotamine mesylate. Headache. 1993; 33(9):471-5. DOI: 10.1111/j.1526-4610.1993.hed3309471.x. View

Rothrock J . Images from headache: a costly attack of migraine. Headache. 2008; 48(6):951. DOI: 10.1111/j.1526-4610.2008.01166.x. View

Ginder S, Oatman B, Pollack M . A prospective study of i.v. magnesium and i.v. prochlorperazine in the treatment of headaches. J Emerg Med. 2000; 18(3):311-5. DOI: 10.1016/s0736-4679(99)00220-6. View

Miller M, Levsky M, Enslow W, Rosin A . Randomized evaluation of octreotide vs prochlorperazine for ED treatment of migraine headache. Am J Emerg Med. 2009; 27(2):160-4. DOI: 10.1016/j.ajem.2008.01.015. View

McCluskey J, Gutteridge D . Avascular necrosis of bone after high doses of dexamethasone during neurosurgery. Br Med J (Clin Res Ed). 1982; 284(6312):333-4. PMC: 1495922. DOI: 10.1136/bmj.284.6312.333. View

Bigal M, Lipton R . Excessive acute migraine medication use and migraine progression. Neurology. 2008; 71(22):1821-8. DOI: 10.1212/01.wnl.0000335946.53860.1d. View

Colman I, Rothney A, Wright S, Zilkalns B, Rowe B . Use of narcotic analgesics in the emergency department treatment of migraine headache. Neurology. 2004; 62(10):1695-700. DOI: 10.1212/01.wnl.0000127304.91605.ba. View

Coppola M, Yealy D, Leibold R . Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache. Ann Emerg Med. 1995; 26(5):541-6. DOI: 10.1016/s0196-0644(95)70001-3. View

10.

Nappi G, SICUTERI F, Byrne M, Roncolato M, Zerbini O . Oral sumatriptan compared with placebo in the acute treatment of migraine. J Neurol. 1994; 241(3):138-44. DOI: 10.1007/BF00868340. View

11.

Scherl E, Wilson J . Comparison of dihydroergotamine with metoclopramide versus meperidine with promethazine in the treatment of acute migraine. Headache. 1995; 35(5):256-9. DOI: 10.1111/j.1526-4610.1995.hed3505256.x. View

12.

Sargent J, Solbach P, Damasio H, Baumel B, Corbett J, Eisner L . A comparison of naproxen sodium to propranolol hydrochloride and a placebo control for the prophylaxis of migraine headache. Headache. 1985; 25(6):320-4. DOI: 10.1111/j.1526-4610.1985.hed2506320.x. View

13.

Watkins S, Williams J . Avascular necrosis of bone after high doses of dexamethasone during neurosurgery. Br Med J (Clin Res Ed). 1982; 284(6317):742. PMC: 1496673. DOI: 10.1136/bmj.284.6317.742-a. View

14.

Weaver C, Jones J, Chisholm C, Foley M, Giles B, Somerville G . Droperidol vs prochlorperazine for the treatment of acute headache. J Emerg Med. 2004; 26(2):145-50. DOI: 10.1016/j.jemermed.2003.05.005. View

15.

Innes G, Macphail I, Dillon E, Metcalfe C, Gao M . Dexamethasone prevents relapse after emergency department treatment of acute migraine: a randomized clinical trial. CJEM. 2007; 1(1):26-33. DOI: 10.1017/s1481803500006989. View

16.

Lane P, McLellan B, Baggoley C . Comparative efficacy of chlorpromazine and meperidine with dimenhydrinate in migraine headache. Ann Emerg Med. 1989; 18(4):360-5. DOI: 10.1016/s0196-0644(89)80570-0. View

17.

Meredith J, Wait S, Brewer K . A prospective double-blind study of nasal sumatriptan versus IV ketorolac in migraine. Am J Emerg Med. 2003; 21(3):173-5. DOI: 10.1016/s0735-6757(02)42256-5. View

18.

Becker W, Riess C, Hoag J . Effectiveness of subcutaneous dihydroergotamine by home injection for migraine. Headache. 1996; 36(3):144-8. DOI: 10.1046/j.1526-4610.1996.3603144.x. View

19.

Hoskin K, Kaube H, Goadsby P . Central activation of the trigeminovascular pathway in the cat is inhibited by dihydroergotamine. A c-Fos and electrophysiological study. Brain. 1996; 119 ( Pt 1):249-56. DOI: 10.1093/brain/119.1.249. View

20.

Morren J, Galvez-Jimenez N . Where is dihydroergotamine mesylate in the changing landscape of migraine therapy?. Expert Opin Pharmacother. 2010; 11(18):3085-93. DOI: 10.1517/14656566.2010.533839. View